- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05231317
Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study (SUSUGUT)
Unhealthy diets are closely linked to non-communicable diseases and constitute higher risk of morbidity and mortality than unsafe sex, alcohol, tobacco and drugs use combined. According to the World Health Organization (WHO), a healthy diet follows a plant-based pattern with low quantities of red meat and a low simple sugar intake. It would also reduce anthropological ecologic impact. We hypothesize that a plant-based diet will beneficially modify the gut microbiota and metabolome, influencing also Trimethylamine N-oxide (TMAO), a metabolite associated to CVD.
This study has a randomized single blind crossover design that compares a plant-based diet towards a control western diet. It is applied to volunteers aged 18-70 years, N=20. Each dietary intervention (plant-based and western) would last for 16 consecutive days separated by a minimum of 7 weeks washout period (intervention 1-washout-intervention 2). Samples of blood urine and faeces will be collected at day 1 and 14 of each intervention. On day 14 will be performed L-carnitine challenge with 1200mg of L-carnitine to test the levels of TMAO), in for the next 2 consecutive days (24h and 48h post treatment).
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Londonderry
-
Coleraine, Londonderry, United Kingdom, BT52 1SA
- Human Intervention Studies Unit, Ulster University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Free-living, apparently healthy adults
- Bmi>18
- Aged 18-70 years at recruitment
- Non-smokers
Exclusion criteria:
- Non-free-living adults
- Adults <18 or >70 years at recruitment
- BMI<18
- Current smokers
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental: Plant-based diet
Diet rich in fruit and vegetables (42% carbohydrates, 17.2% fibres; 15% proteins and 43% fats).
|
16 days with all foods provided
|
Active Comparator: Active Comparator: Western diet
Diet Rich in Processed Foods (48% carbohydrates, 10.4% fibres; 14% proteins and 39% fats).
|
16 days with all foods provided
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gut microbiota changes
Time Frame: Change over 14 days
|
Significant changes in the number of bifidobacteria
|
Change over 14 days
|
Quantification of Trimethylamine N-oxide
Time Frame: Day 16
|
Changes in response to L-Carnitine challenge
|
Day 16
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Bioactivity of faecal water
Time Frame: Change over 14 days
|
Measured by using faecal water as basis for growth media (ex vivo measure)
|
Change over 14 days
|
Effects on inflammatory markers of both diets
Time Frame: Change over 14 days
|
Cytokine analysis via ELISA test (MagPix)
|
Change over 14 days
|
Ex vivo effects of faecal water on gut pathobionts
Time Frame: Day 14
|
Co-culturing the aqueous phase of faeces with C. difficile to assess changes in its biology
|
Day 14
|
Quantification of phytochemicals
Time Frame: Change over 14 days
|
Measured by LC-MS
|
Change over 14 days
|
Quantification of Short Chain Fatty Acids (SCFA)
Time Frame: Change over 14 days
|
Measured by nuclear magnetic resonance (NMR)
|
Change over 14 days
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- REC/20/0008
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Microbiota
-
Microbio Co LtdCompleted
-
University of California, Los AngelesCompleted
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaCompleted
-
Manchester University NHS Foundation TrustUniversity of ManchesterRecruiting
-
University of ManitobaAlmond Board of CaliforniaTerminated
-
Kimberly-Clark CorporationWithdrawn
-
Afyonkarahisar Health Sciences UniversityNot yet recruiting
-
Third Affiliated Hospital, Sun Yat-Sen UniversityCompleted
-
Hadassah Medical OrganizationBar-Ilan University, IsraelWithdrawn
-
Samara State Medical UniversityRecruitingOral MicrobiotaRussian Federation
Clinical Trials on Plant-based diet
-
University of MinnesotaCompleted
-
Taipei Veterans General Hospital, TaiwanRecruiting
-
Montefiore Medical CenterThe Purjes Foundation; The Greenbaum FoundationRecruiting
-
George Washington UniversityNot yet recruitingInflammation | Hypertension | Diabetes Mellitus | Metabolic Syndrome | Dietary Habits | Kidney Disease, Chronic | Kidney Transplant Failure | Transplant Complication
-
Mayo ClinicCompleted
-
Charite University, Berlin, GermanyCharite University, Department for Dental MedicineCompletedMetabolic Syndrome | Overweight and Obesity | Cardiovascular Risk Factor | Hypertension,EssentialGermany
-
Vanderbilt University Medical CenterSeth BordensteinCompletedDiet Modification | Microbial ColonizationUnited States
-
Vascular Institute of TexasUnknownPeripheral Arterial DiseaseUnited States
-
Physicians Committee for Responsible MedicineRecruiting
-
Morehouse School of MedicineEmory UniversityRecruiting